Accuracy of fluorocrit in determination of blood perflubron concentration

被引:2
作者
Henry, CJ
Tyler, JW
Fields, T
Brewer, WG
Royer, N
机构
[1] Univ Missouri, Dept Vet Med & Surg, Columbia, MO 65211 USA
[2] Alliance Pharmaceut Corp, San Diego, CA 92121 USA
[3] Auburn Univ, Coll Vet Med, Dept Small Anim Surg & Med, Auburn, AL 36849 USA
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY | 1998年 / 26卷 / 03期
关键词
D O I
10.3109/10731199809117459
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Previous studies examining the radiosensitizing effects of perfluorochemical emulsions have based dose recommendations on a measurement known as fluorocrit. The fluorocrit is the proportion of blood volume occupied by perfluorochemicals and is measured using standard hematocrit procedures. This measurement is inherently crude and subject to error and variability between different individuals measuring the same sample. Furthermore, the fluorocrit method has not been compared to other quantitative methods to determine its reliability. The purpose of this study was to compare fluorocrit measurements to those obtained by gas chromatographic analysis. A 90% w/v perflubron emulsion was administered to six normal dogs once weekly for four weeks and peripheral blood samples were obtained at specified time points for analysis. A total of 123 blood samples were analyzed by both methods. The relationship between blood fluorocrit and plasma perflubron concentration measured by gas chromatography was examined using regression models. Based on the modest predictive value (r(2) = 0.3683) of the derived statistical model, we conclude that fluorocrit measurement is an inaccurate method of estimation of blood perflubron concentration. Caution must, therefore, be exercised when extrapolating data and dose recommendations from reports of studies using fluorocrit as the only estimate of blood perflubron concentration.
引用
收藏
页码:285 / 292
页数:8
相关论文
共 26 条
[1]  
ARLEN C, 1988, BIOMAT ART CELLS ART, V44, P445
[2]  
BEARD CJ, 1993, CANC PRINCIPLES PRAC, P2701
[3]   Hypoxia-specific cytotoxins in cancer therapy [J].
Brown, JM ;
Sum, BG .
SEMINARS IN RADIATION ONCOLOGY, 1996, 6 (01) :22-36
[4]   ACUTE AND SUBACUTE TOXICITY OF 100-PERCENT PFOB EMULSION [J].
BURGAN, AR ;
HERRICK, WC ;
LONG, DM ;
LONG, DC .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1988, 16 (1-3) :681-682
[5]   INCREASE IN TUMOR PO2 BY PERFLUOROCHEMICALS AND CARBOGEN [J].
HASEGAWA, T ;
RHEE, JG ;
LEVITT, SH ;
SONG, CW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (04) :569-574
[6]   PHARMACOKINETICS AND TOLERANCE OF WEEKLY OXYGENT(TM) CA INFUSIONS IN THE DOG [J].
HENRY, CJ ;
BREWER, WG ;
HENDERSON, RA ;
BRAWNER, WR .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (04) :1155-1160
[7]   ENHANCEMENT BY PERFLUSION EMULSION (OXYGENT(R)) AND CARBOGEN BREATHING OF THE TUMOR-GROWTH DELAY OF THE FSAIIC FIBROSARCOMA AFTER TREATMENT WITH ANTITUMOR ALKYLATING-AGENTS [J].
HOLDEN, SA ;
TEICHER, BA ;
HA, C ;
ARA, G ;
HERMAN, TS .
BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY, 1992, 20 (2-4) :895-898
[8]   OVERCOMING TUMOR RADIATION-RESISTANCE RESULTING FROM ACUTE-HYPOXIA [J].
HORSMAN, MR ;
OVERGAARD, J .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :717-718
[9]   PREPARATION AND APPLICATION OF HIGHLY CONCENTRATED PERFLUOROCTYLBROMIDE FLUOROCARBON EMULSIONS [J].
LONG, DC ;
LONG, DM ;
RIESS, J ;
FOLLANA, R ;
BURGAN, A ;
MATTREY, RF .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1988, 16 (1-3) :441-442
[10]   PHASE-I/II STUDY OF FLUOSOL-DA AND 100-PERCENT OXYGEN AS AN ADJUVANT TO RADIATION IN THE TREATMENT OF ADVANCED SQUAMOUS-CELL TUMORS OF THE HEAD AND NECK [J].
LUSTIG, R ;
MCINTOSHLOWE, N ;
ROSE, C ;
HAAS, J ;
KRASNOW, S ;
SPAULDING, M ;
PROSNITZ, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (06) :1587-1593